CL: Colgate-Palmolive Company Financials
Colgate-Palmolive Company Income Statement
Total revenue
Net income
Gross margin TTM
60.11%
Operating margin TTM
21.33%
Net profit margin TTM
10.46%
Return on investment TTM
3,948.15%
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 20,382,000,000 | 20,101,000,000 | 19,457,000,000 | 17,967,000,000 |
| Operating income | 4,348,000,000 | 4,383,000,000 | 4,131,000,000 | 3,585,000,000 |
| Net income | 2,132,000,000 | 2,889,000,000 | 2,300,000,000 | 1,785,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 20,382,000,000 | 20,101,000,000 | 19,457,000,000 | 17,967,000,000 |
| Cost of revenue | 8,131,000,000 | 7,995,000,000 | 8,206,000,000 | 7,817,000,000 |
| Gross profit | 12,251,000,000 | 12,106,000,000 | 11,251,000,000 | 10,150,000,000 |
| Research and development expenses | 0 | 355,000,000 | 343,000,000 | 320,000,000 |
| General and administrative expenses | 0 | 5,090,000,000 | 0 | 0 |
| Selling and marketing expenses | 0 | 2,720,000,000 | 0 | 0 |
| Selling, general and administrative expenses | 7,903,000,000 | 7,810,000,000 | 6,777,000,000 | 6,245,000,000 |
| Other expenses | 0 | -442,000,000 | 0 | 0 |
| Operating expenses | 7,903,000,000 | 7,723,000,000 | 7,120,000,000 | 6,565,000,000 |
| Cost and expenses | 16,034,000,000 | 15,718,000,000 | 15,326,000,000 | 14,382,000,000 |
| Net interest income | -192,000,000 | -225,000,000 | -232,000,000 | -153,000,000 |
| Interest income | 75,000,000 | 67,000,000 | 55,000,000 | 14,000,000 |
| Interest expense | 267,000,000 | 292,000,000 | 287,000,000 | 167,000,000 |
| Depreciation and amortization | 630,000,000 | 605,000,000 | 567,000,000 | 545,000,000 |
| EBITDA | 3,956,000,000 | 4,853,000,000 | 4,246,000,000 | 3,372,000,000 |
| EBIT | 3,326,000,000 | 4,248,000,000 | 3,679,000,000 | 2,827,000,000 |
| Non-operating income (excl. interest) | 1,022,000,000 | 135,000,000 | 452,000,000 | 758,000,000 |
| Operating income | 4,348,000,000 | 4,383,000,000 | 4,131,000,000 | 3,585,000,000 |
| Total other income/expenses (net) | -1,289,000,000 | -427,000,000 | -739,000,000 | -925,000,000 |
| Income before tax | 3,059,000,000 | 3,956,000,000 | 3,392,000,000 | 2,660,000,000 |
| Income tax expense | 798,000,000 | 907,000,000 | 937,000,000 | 693,000,000 |
| Net income from continuing operations | 2,261,000,000 | 3,049,000,000 | 2,455,000,000 | 1,967,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 2,132,000,000 | 2,889,000,000 | 2,300,000,000 | 1,785,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 2,132,000,000 | 2,889,000,000 | 2,300,000,000 | 1,785,000,000 |
| EPS | 3 | 4 | 3 | 2 |
| Diluted EPS | 3 | 4 | 3 | 2 |
| Weighted average shares outstanding | 808,700,000 | 817,700,000 | 827,400,000 | 836,400,000 |
| Weighted average diluted shares outstanding | 811,100,000 | 822,500,000 | 829,200,000 | 838,800,000 |
Colgate-Palmolive Company Balance Sheet
Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
7,988,000,000%
Total debt / assets MRQ
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total assets | 16,330,000,000 | 16,046,000,000 | 16,393,000,000 | 15,731,000,000 |
| Total liabilities | 15,965,000,000 | 15,502,000,000 | 15,436,000,000 | 14,925,000,000 |
| Total equity | 54,000,000 | 212,000,000 | 609,000,000 | 401,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,288,000,000 | 1,096,000,000 | 966,000,000 | 775,000,000 |
| Short-term investments | 0 | 160,000,000 | 0 | 0 |
| Cash and short-term investments | 1,288,000,000 | 1,256,000,000 | 966,000,000 | 775,000,000 |
| Net receivables | 1,675,000,000 | 1,521,000,000 | 1,586,000,000 | 1,504,000,000 |
| Accounts receivable | 1,675,000,000 | 1,521,000,000 | 1,586,000,000 | 1,504,000,000 |
| Other receivables | 0 | 0 | 0 | 0 |
| Inventory | 2,032,000,000 | 1,987,000,000 | 1,934,000,000 | 2,074,000,000 |
| Prepaid expenses | 0 | 0 | 0 | 0 |
| Other current assets | 714,000,000 | 553,000,000 | 793,000,000 | 760,000,000 |
| Total current assets | 5,709,000,000 | 5,317,000,000 | 5,279,000,000 | 5,113,000,000 |
| Property, plant and equipment (net) | 4,660,000,000 | 4,422,000,000 | 4,582,000,000 | 4,307,000,000 |
| Goodwill | 3,122,000,000 | 3,272,000,000 | 3,410,000,000 | 3,352,000,000 |
| Intangible assets | 1,536,000,000 | 1,756,000,000 | 1,887,000,000 | 1,920,000,000 |
| Goodwill and intangible assets | 4,658,000,000 | 5,028,000,000 | 5,297,000,000 | 5,272,000,000 |
| Long-term investments | 0 | 81,000,000 | 0 | 0 |
| Tax assets | 205,000,000 | 195,000,000 | 214,000,000 | 135,000,000 |
| Other non-current assets | 1,098,000,000 | 1,003,000,000 | 1,021,000,000 | 904,000,000 |
| Total non-current assets | 10,621,000,000 | 10,729,000,000 | 11,114,000,000 | 10,618,000,000 |
| Other assets | 0 | 0 | 0 | 0 |
| Total assets | 16,330,000,000 | 16,046,000,000 | 16,393,000,000 | 15,731,000,000 |
| Total payables | 0 | 2,778,000,000 | 2,201,000,000 | 2,001,000,000 |
| Accounts payable | 0 | 1,805,000,000 | 1,698,000,000 | 1,551,000,000 |
| Other payables | 0 | 973,000,000 | 503,000,000 | 450,000,000 |
| Accrued expenses | 0 | 2,098,000,000 | 1,993,000,000 | 1,773,000,000 |
| Short-term debt | 0 | 660,000,000 | 330,000,000 | 25,000,000 |
| Capital lease obligations (current) | 0 | 107,000,000 | 95,000,000 | 108,000,000 |
| Tax payables | 0 | 565,000,000 | 503,000,000 | 450,000,000 |
| Deferred revenue | 0 | 0 | 0 | 0 |
| Other current liabilities | 5,736,000,000 | 116,000,000 | 122,000,000 | 97,000,000 |
| Total current liabilities | 5,736,000,000 | 5,759,000,000 | 4,741,000,000 | 4,004,000,000 |
| Long-term debt | 7,988,000,000 | 7,289,000,000 | 8,219,000,000 | 8,741,000,000 |
| Capital lease obligations (non-current) | 0 | 456,000,000 | 420,000,000 | 397,000,000 |
| Deferred revenue (non-current) | 0 | 0 | 0 | 0 |
| Deferred tax liabilities (non-current) | 0 | 343,000,000 | 361,000,000 | 383,000,000 |
| Other non-current liabilities | 2,241,000,000 | 1,655,000,000 | 1,695,000,000 | 1,400,000,000 |
| Total non-current liabilities | 10,229,000,000 | 9,743,000,000 | 10,695,000,000 | 10,921,000,000 |
| Other liabilities | 0 | 0 | 0 | 0 |
| Capital lease obligations | 0 | 563,000,000 | 515,000,000 | 505,000,000 |
| Total liabilities | 15,965,000,000 | 15,502,000,000 | 15,436,000,000 | 14,925,000,000 |
| Treasury stock | -28,450,000,000 | -27,358,000,000 | -26,017,000,000 | -25,128,000,000 |
| Preferred stock | 0 | 0 | 0 | 0 |
| Common stock | 1,466,000,000 | 1,466,000,000 | 1,466,000,000 | 1,466,000,000 |
| Retained earnings | 26,595,000,000 | 26,145,000,000 | 25,289,000,000 | 24,573,000,000 |
| Additional paid-in capital | 4,322,000,000 | 4,181,000,000 | 3,808,000,000 | 3,546,000,000 |
| Accumulated other comprehensive income/loss | -3,879,000,000 | -4,222,000,000 | -3,937,000,000 | -4,055,000,000 |
| Other stockholders' equity | 0 | 0 | 0 | -1,000,000 |
| Total stockholders' equity | 54,000,000 | 212,000,000 | 609,000,000 | 401,000,000 |
| Total equity | 365,000,000 | 544,000,000 | 957,000,000 | 806,000,000 |
| Minority interest | 311,000,000 | 332,000,000 | 348,000,000 | 405,000,000 |
| Total liabilities and total equity | 16,330,000,000 | 16,046,000,000 | 16,393,000,000 | 15,731,000,000 |
| Total investments | 0 | 241,000,000 | 0 | 0 |
| Total debt | 7,988,000,000 | 8,512,000,000 | 9,064,000,000 | 9,271,000,000 |
| Net debt | 6,700,000,000 | 7,416,000,000 | 8,098,000,000 | 8,496,000,000 |
Colgate-Palmolive Company Cash Flow Statement
Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash from operations | 4,198,000,000 | 4,107,000,000 | 3,745,000,000 | 2,556,000,000 |
| Cash from investing | -817,000,000 | -534,000,000 | -742,000,000 | -1,601,000,000 |
| Cash from financing | -3,256,000,000 | -3,389,000,000 | -2,793,000,000 | -952,000,000 |
| Net change in cash | 192,000,000 | 130,000,000 | 191,000,000 | -57,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Net income | 2,132,000,000 | 3,049,000,000 | 2,455,000,000 | 1,967,000,000 |
| Depreciation and amortization | 630,000,000 | 605,000,000 | 567,000,000 | 545,000,000 |
| Deferred income tax | -109,000,000 | -77,000,000 | -98,000,000 | -78,000,000 |
| Stock-based compensation | 0 | 135,000,000 | 122,000,000 | 125,000,000 |
| Change in working capital | 284,000,000 | 344,000,000 | 455,000,000 | -726,000,000 |
| Accounts receivable | -16,000,000 | -56,000,000 | -37,000,000 | -227,000,000 |
| Inventory | 109,000,000 | -100,000,000 | 194,000,000 | -333,000,000 |
| Accounts payable | 251,000,000 | 516,000,000 | 0 | 0 |
| Other working capital | -60,000,000 | -16,000,000 | 298,000,000 | -166,000,000 |
| Other non-cash items | 1,261,000,000 | 51,000,000 | 244,000,000 | 723,000,000 |
| Net cash from operating activities | 4,198,000,000 | 4,107,000,000 | 3,745,000,000 | 2,556,000,000 |
| Investments in property, plant and equipment | -564,000,000 | -561,000,000 | -705,000,000 | -696,000,000 |
| Acquisitions (net) | -293,000,000 | 0 | 0 | -809,000,000 |
| Purchases of investments | -698,000,000 | -574,000,000 | -506,000,000 | -470,000,000 |
| Sales/maturities of investments | 752,000,000 | 564,000,000 | 502,000,000 | 322,000,000 |
| Other investing activities | -14,000,000 | 37,000,000 | -33,000,000 | 52,000,000 |
| Net cash from investing activities | -817,000,000 | -534,000,000 | -742,000,000 | -1,601,000,000 |
| Net debt issuance | -456,000,000 | -408,000,000 | -314,000,000 | 1,647,000,000 |
| Long-term net debt issuance | 533,000,000 | -501,000,000 | 592,000,000 | 1,107,000,000 |
| Short-term net debt issuance | -989,000,000 | 93,000,000 | -906,000,000 | 540,000,000 |
| Net stock issuance | -1,109,000,000 | -1,739,000,000 | -1,128,000,000 | -1,308,000,000 |
| Net common stock issuance | -1,109,000,000 | -1,739,000,000 | -1,128,000,000 | -1,308,000,000 |
| Common stock issuance | 101,000,000 | 0 | 0 | 0 |
| Common stock repurchased | -1,210,000,000 | -1,739,000,000 | -1,128,000,000 | -1,308,000,000 |
| Net preferred stock issuance | 0 | 0 | 0 | 0 |
| Net dividends paid | -1,823,000,000 | -1,789,000,000 | -1,749,000,000 | -1,691,000,000 |
| Common dividends paid | -1,823,000,000 | -1,789,000,000 | -1,749,000,000 | -1,691,000,000 |
| Preferred dividends paid | 0 | 0 | 0 | 0 |
| Other financing activities | 132,000,000 | 547,000,000 | 398,000,000 | 400,000,000 |
| Net cash from financing activities | -3,256,000,000 | -3,389,000,000 | -2,793,000,000 | -952,000,000 |
| Effect of FX changes on cash | 67,000,000 | -54,000,000 | -19,000,000 | -60,000,000 |
| Net change in cash | 192,000,000 | 130,000,000 | 191,000,000 | -57,000,000 |
| Cash at end of period | 1,288,000,000 | 1,096,000,000 | 966,000,000 | 775,000,000 |
| Cash at beginning of period | 1,096,000,000 | 966,000,000 | 775,000,000 | 832,000,000 |
| Operating cash flow | 4,198,000,000 | 4,107,000,000 | 3,745,000,000 | 2,556,000,000 |
| Capital expenditure | -564,000,000 | -561,000,000 | -705,000,000 | -696,000,000 |
| Free cash flow | 3,634,000,000 | 3,546,000,000 | 3,040,000,000 | 1,860,000,000 |
| Income taxes paid | 0 | 933,000,000 | 937,000,000 | 945,000,000 |
| Interest paid | 270,000,000 | 302,000,000 | 280,000,000 | 151,000,000 |